Purification and characterization of human lung fibroblast motility-stimulating factor for human soft tissue sarcoma cells: identification as an NH2-terminal fragment of human fibronectin.

Paracrine motogenic factors, including motility cytokines and extracellular matrix molecules secreted by normal cells, can stimulate metastatic cell invasion. Both intact extracellular matrix molecules and their degradative products may exhibit these activities. We have found that human lung fibroblasts produce paracrine motility-stimulating factors for recently established human sarcoma cell strains. We purified the major fibroblast motility-stimulating factor (FMSF) from human lung fibroblast-conditioned medium by sequential heparin affinity chromatography and DEAE anion exchange chromatography. Lysylendopeptidase C digestion of FMSF and sequencing of peptides purified by reverse-phase high-pressure liquid chromatography identified FMSF as an NH2-terminal fragment of human fibronectin. Using SYN-1 sarcoma cells, FMSF predominantly stimulated chemotaxis and some chemokinesis, and it was chemotactic for a variety of human sarcoma cells, including fibrosarcoma, leiomyosarcoma, liposarcoma, synovial sarcoma, and neurofibrosarcoma cells. The FMSF activity present in human lung fibroblast-conditioned medium was completely eliminated by either neutralization or immunodepletion with a rabbit antihuman-fibronectin antibody, thus further confirming that the NH2-terminal fibronectin fragment was the FMSF responsible for the motility stimulation of human soft tissue sarcoma cells. Because human soft tissue sarcomas have a distinctive hematogenous metastatic pattern (predominantly lung), and lung-derived fibroblasts secrete large amounts of FMSF, FMSF and fibronectin may play a role in stimulating sarcoma invasion into lung tissue.

[1]  T Shinozaki,et al.  Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide. , 1996, Cancer research.

[2]  H. Yajima,et al.  Release of biological activities from quiescent fibronectin by a conformational change and limited proteolysis by matrix metalloproteinases. , 1995, Biochemistry.

[3]  R. Pollock,et al.  Human peri‐tumoral and lung fibroblasts produce paracrine motility factors for recently established human sarcoma cell strains , 1995, International journal of cancer.

[4]  M. Schwartz,et al.  Integrins: emerging paradigms of signal transduction. , 1995, Annual review of cell and developmental biology.

[5]  Y. Yamaguchi,et al.  Purification and biological characterization of epitaxin, a fibroblast-derived motility factor for epithelial cells. , 1994, The Journal of biological chemistry.

[6]  M. Kang,et al.  A candidate molecule for the matrix assembly receptor to the N-terminal 29-kDa fragment of fibronectin in chick myoblasts. , 1994, The Journal of biological chemistry.

[7]  G. Nicolson,et al.  A paracrine migration-stimulating factor for metastatic tumor cells secreted by mouse hepatic sinusoidal endothelial cells: identification as complement component C3b. , 1993, Cancer research.

[8]  A. Schor,et al.  Migration stimulating factor (MSF): its structure, mode of action and possible function in health and disease. , 1993, Symposia of the Society for Experimental Biology.

[9]  B. Chait,et al.  Weighing naked proteins: practical, high-accuracy mass measurement of peptides and proteins. , 1992, Science.

[10]  S. Blystone,et al.  Isolation of an amino-terminal fibronectin-binding protein on human U937 cells and rat peritoneal macrophages. , 1992, The Journal of biological chemistry.

[11]  L. Liotta,et al.  Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. , 1992, The Journal of biological chemistry.

[12]  R. Mecham,et al.  Impaired elastin fiber assembly related to reduced 67-kD elastin-binding protein in fetal lamb ductus arteriosus and in cultured aortic smooth muscle cells treated with chondroitin sulfate. , 1991, The Journal of clinical investigation.

[13]  J. Schwarzbauer Identification of the fibronectin sequences required for assembly of a fibrillar matrix , 1991, The Journal of cell biology.

[14]  A. Tsugita,et al.  Rat plasma fibronectin contains two distinct chemotactic domains for fibroblastic cells. , 1991, The Journal of biological chemistry.

[15]  E. Gherardi,et al.  Regulation of cell movement: the motogenic cytokines. , 1991, Biochimica et biophysica acta.

[16]  L. Liotta,et al.  Increased expression of the laminin receptor in human colon cancer. , 1991, Journal of the National Cancer Institute.

[17]  L. Liotta,et al.  The capsule surrounding primary liver tumors: Wherefrom its prognostic significance? , 1990, International journal of cancer.

[18]  M. Kang,et al.  Correlation between fibronectin and its receptor in chick myoblast differentiation , 1990, Journal of cellular physiology.

[19]  L. Liotta,et al.  The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells. , 1989, The Journal of biological chemistry.

[20]  L. Liotta,et al.  The elastin receptor shows structural and functional similarities to the 67-kDa tumor cell laminin receptor. , 1989, The Journal of biological chemistry.

[21]  S. Nathanson,et al.  Organ-specific chemotactic factors present in lung extracellular matrix. , 1989, The Journal of surgical research.

[22]  A. Schor,et al.  Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[23]  F. Blumenstock,et al.  Fibronectin augments binding of fibrin to macrophages. , 1989, The Journal of laboratory and clinical medicine.

[24]  B. Quade,et al.  Fibronectin's amino-terminal matrix assembly site is located within the 29-kDa amino-terminal domain containing five type I repeats. , 1988, The Journal of biological chemistry.

[25]  B. Zetter,et al.  Identification of a tumor cell receptor for VGVAPG, an elastin-derived chemotactic peptide , 1988, The Journal of cell biology.

[26]  E. Kandel,et al.  Sequencing of proteins from two-dimensional gels by using in situ digestion and transfer of peptides to polyvinylidene difluoride membranes: application to proteins associated with sensitization in Aplysia. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R. Clark,et al.  Cryptic chemotactic activity of fibronectin for human monocytes resides in the 120-kDa fibroblastic cell-binding fragment. , 1988, The Journal of biological chemistry.

[28]  E. Kohn,et al.  Insulin-like growth factors stimulate chemotaxis in human melanoma cells. , 1988, Biochemical and biophysical research communications.

[29]  M. Moos,et al.  Reproducible high yield sequencing of proteins electrophoretically separated and transferred to an inert support. , 1988, The Journal of biological chemistry.

[30]  J. McDonald Extracellular matrix assembly. , 1988, Annual review of cell biology.

[31]  R. Perris,et al.  Amphibian neural crest cell migration on purified extracellular matrix components: a chondroitin sulfate proteoglycan inhibits locomotion on fibronectin substrates , 1987, The Journal of cell biology.

[32]  H. Kleinman,et al.  YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation. , 1987, Science.

[33]  L. Liotta,et al.  Role of laminin receptor in tumor cell migration. , 1987, Cancer research.

[34]  L. Liotta,et al.  Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains , 1987, The Journal of cell biology.

[35]  L. Hood,et al.  Internal amino acid sequence analysis of proteins separated by one- or two-dimensional gel electrophoresis after in situ protease digestion on nitrocellulose. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[36]  G. Nicolson,et al.  Chemotactic response of rat mammary adenocarcinoma cell clones to tumor-derived cytokines. , 1987, Biochemical and biophysical research communications.

[37]  B. Quade,et al.  Fibronectin's cell-adhesive domain and an amino-terminal matrix assembly domain participate in its assembly into fibroblast pericellular matrix. , 1987, The Journal of biological chemistry.

[38]  A. Horwitz,et al.  Cell surface receptors for extracellular matrix molecules. , 1987, Annual review of cell biology.

[39]  A. Kornblihtt,et al.  Human fibronectin is synthesized as a pre‐propolypeptide , 1986, FEBS letters.

[40]  L. Culp,et al.  Substratum contacts and cytoskeletal reorganization of BALB/c 3T3 cells on a cell-binding fragment and heparin-binding fragments of plasma fibronectin. , 1986, Experimental cell research.

[41]  L. Liotta,et al.  Tumor cell autocrine motility factor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[42]  A. Woods,et al.  Adhesion and cytoskeletal organisation of fibroblasts in response to fibronectin fragments. , 1986, The EMBO journal.

[43]  J. McCarthy,et al.  Human fibronectin contains distinct adhesion- and motility-promoting domains for metastatic melanoma cells , 1986, The Journal of cell biology.

[44]  A. Kornblihtt,et al.  Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene. , 1985, The EMBO journal.

[45]  K. Sekiguchi,et al.  Differences in domain structure between human fibronectins isolated from plasma and from culture supernatants of normal and transformed fibroblasts. Studies with domain-specific antibodies. , 1985, The Journal of biological chemistry.

[46]  P. McKeown-Longo,et al.  Interaction of the 70,000-mol-wt amino-terminal fragment of fibronectin with the matrix-assembly receptor of fibroblasts , 1985, The Journal of cell biology.

[47]  R. Hynes,et al.  Multiple fibronectin subunits and their post-translational modifications. , 1984, The Journal of biological chemistry.

[48]  J. McCarthy,et al.  Laminin and fibronectin promote the haptotactic migration of B16 mouse melanoma cells in vitro , 1984, The Journal of cell biology.

[49]  R. Laine,et al.  Human placental (fetal) fibronectin: increased glycosylation and higher protease resistance than plasma fibronectin. Presence of polylactosamine glycopeptides and properties of a 44-kilodalton chymotryptic collagen-binding domain: difference from human plasma fibronectin. , 1984, The Journal of biological chemistry.

[50]  B. Frangione,et al.  Primary structure of human plasma fibronectin. The 29,000-dalton NH2-terminal domain. , 1983, The Journal of biological chemistry.

[51]  M. Humphries,et al.  Stimulation of DNA synthesis by cathepsin D digests of fibronectin , 1983, Nature.

[52]  L. Liotta,et al.  Tumor invasion and the extracellular matrix. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[53]  R. Mecham,et al.  Chemotactic responses of fibroblasts to tropoelastin and elastin-derived peptides. , 1982, The Journal of clinical investigation.

[54]  K. Yamada,et al.  Divalent cation modulation of fibronectin binding to heparin and to DNA. , 1982, The Journal of biological chemistry.

[55]  D. Rowe,et al.  Collagen and collagen-derived fragments are chemotactic for tumor cells. , 1981, The Journal of clinical investigation.

[56]  D. Mosher Cross-linking of cold-insoluble globulin by fibrin-stabilizing factor. , 1975, The Journal of biological chemistry.

[57]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.